Best month-to-month injection-plan comparisons: ways to limit upfront commitment
For a first injection prescription, the amount committed today may matter as much as an annualized rate. A monthly option can leave less cash tied up before response
Article updated
Read this firstArticle updated November 13, 2026; source dates below
Look for both a one-month payment and a one-month obligation; the two are not always the same.
Likeness semaglutide
$139 monthly
One-month medicine offer; selected agreement applies.
For a first injection prescription, the amount committed today may matter as much as an annualized rate. A monthly option can leave less cash tied up before response is reviewed, while still creating recurring charges. This list compares seven payment structures without calling every advertised option commitment-free.
Injection Index focuses on the selected month-to-month route and the alternatives around it. A multi-month or annual discount may appear during checkout, so the actual order must be identified. A smaller first payment does not establish a better medical choice or remove the need for review.
Semaglutide $948/year ($79/mo equivalent) or $139 month-to-month; tirzepatide terms differ
Likeness Rx offers compounded semaglutide and tirzepatide with explicit term pricing. Its lowest advertised monthly equivalents are $79 and $129 on annual prepaid terms; month-to-month options cost more.
Trimi explicitly separates an annual monthly equivalent from the upfront bill: semaglutide is advertised at $1,188 for twelve months, with a different month-to-month rate.
A monthly debit can still sit inside a longer contract
Likeness and Trimi publish explicit month-to-month medication rates. Ro publishes a month-to-month membership rate with the drug separate. These are useful examples for reading a selected agreement, but they should not be treated as identical treatment bundles.
Check the cancellation cutoff, pharmacy-processing stage and next prescription review. A shorter financial commitment can be useful while assessing a new care relationship, but it does not remove the need for ongoing medical follow-up or make an already processed order refundable.
Before you decide
Questions worth answering
Does the order on this page identify the best treatment for me?
No. It is a publisher-arranged comparison of selected public offers. The chart explains the specific purchase or evidence question; a licensed clinician must assess the actual treatment.
What should I verify for this comparison?
Look for both a one-month payment and a one-month obligation; the two are not always the same. Ask for the selected written quote and the product-specific clinical explanation before making a purchase.
Evidence behind this page
Sources & chart notes
Source dates are listed with each document. Earlier research and later offer updates are identified separately. Provider pages establish advertised terms. Labels and trial reports describe specific medicines and study populations. Medical review has not been completed.
Best month-to-month injection-plan comparisons: ways to limit upfront commitment — use the complete product record to compare formats and purchase terms.
What makes this shortlist useful
Write down the selected payment period, amount due now, next charge and cancellation deadline. Keep medication separate from membership where it is not included. A monthly plan can still renew automatically, while an annual equivalent can require advance payment. Confirm the actual prescription and supply rather than selecting a different treatment simply to match a cheaper payment period. Read the related care guide for a wider treatment discussion.
What makes this shortlist useful — keep the exact product identity and its complete label together.
1. CoreAge Rx: a stated ingredient-specific monthly route
CoreAge provides clinician assessment and a compounded injection pathway with a stated ingredient-specific starting rate. Its product pages separate semaglutide from tirzepatide. The prescription, concentration and amount dispensed should be confirmed rather than inferred from the price or transferred from another provider’s vial instructions. The page’s monthly offer and no-long-term-contract claim can prompt a commitment discussion. Confirm repeat ordering and the actual supply, keeping the semaglutide and tirzepatide prices separately named.
CoreAge’s linked promotion advertises compounded semaglutide at $79 per month and tirzepatide at $129. Read the dated CoreAge Rx update before using a main-product price; retain the selected offer and confirm the commitment and amount due. Confirm the actual amount, billing interval and dispensing pharmacy. Its refund policy has pharmacy-approval and elapsed-time limits; cancellation should not be assumed to refund a prepared prescription.
SuperHealthy Rx advertises compounded semaglutide from $85/month and tirzepatide from $135/month. The linked offer says the provider visit and shipping are included. Confirm the amount due, plan term and refill settings; a prescription depends on clinician review. These are published service terms, not independently tested outcomes. Read the SuperHealthy Rx review.
SuperHealthy Rx: compare the selected agreement with the questions in this section.
3. Likeness Rx — GLP-1 weight care
Read the preparation and recurring invoice together. Likeness Rx offers online access to compounded semaglutide and tirzepatide. Its public page lists semaglutide from $79/month; tirzepatide from $129/month.
The lowest monthly equivalents accompany 12-month subscriptions: $948 for semaglutide or $1,548 for tirzepatide. One-month plans are $139 and $199. The page says the selected term renews automatically; check the amount due and cancellation date.
The public site describes licensed-provider review, shipping after approval and care-team messaging. Those are service statements rather than measured response times.
These are provider-published terms checked October 4, 2026. Prescription approval is conditional. Compounded medications are not FDA-approved; we have not tested the treatment, pharmacy fulfillment or patient outcomes.
Product and subscription information checked at likenessrx.com on October 4, 2026.
4. Trimi: an explicit monthly-versus-annual choice
Trimi describes individualized compounded semaglutide and tirzepatide prescriptions with provider review, supplies and shipment. It offers materially different annual and monthly payment commitments. The named pharmacy pathway helps identify what to ask, while regulatory status and clinical rationale still need separate consideration. Trimi’s stated month-to-month option gives a clear contrast with annual prepayment. The higher monthly rate may be relevant to a patient prioritizing a smaller first commitment rather than the lowest yearly equivalent.
Trimi’s current compounded semaglutide choices are $175 month-to-month or a $99 monthly equivalent on a twelve-month commitment billed $1,188 upfront. Tirzepatide is $235 monthly or $125 equivalent with $1,500 upfront. It lists provider review, supplies and shipping with no membership fee. Confirm selected term, actual amount supplied and refund rules; the annual equivalent is not a monthly payment.
Read the full Trimi review to compare the care pathway, prescription and recurring order.
Trimi: compare the selected agreement with the questions in this section.
5. SnagRx: monthly orders versus discounted terms
SnagRx describes a clinician-reviewed compounded supply with a patient portal for refills. Its marketing separates no-membership pricing from selected subscription discounts. The product and pharmacy remain individualized prescription facts, while its prominent promotional price needs a term and renewal check. The service distinguishes flexible monthly cancellation from subscribe-and-save commitments. Check which route is selected and how its promotion and refund rules apply, rather than assuming all prices share the same flexibility.
SnagRx currently promotes compounded semaglutide at $69 and tirzepatide at $119 per month, with medication, supplies, doctor review and free shipping described as included. It distinguishes month-to-month cancellation from subscribe-and-save term discounts. Sales are generally final, with unused-term refunds tied to medical ineligibility. Confirm promotion eligibility, selected term, quantity and renewal before treating the floor as guaranteed indefinitely.
Read the full SnagRx review to compare the care pathway, prescription and recurring order.
6. Ro: monthly care with medicine extra
Ro’s Body route separates a clinical membership from medication. The current page describes access to FDA-approved products, insurance support, provider messaging and care. That structure is useful to compare with medicine-inclusive bundles, while a membership floor alone does not identify the total treatment cost. Ro’s monthly membership is distinct from its prepaid term options. Add the actual medicine quotation, since avoiding annual access prepayment does not identify the separate pharmacy payment period or treatment cost.
Ro currently charges $39 for the first membership month, then $149 month-to-month or a $74 monthly equivalent on annual prepayment. Six- and three-month equivalents are $89 and $99, respectively. Medication is extra and depends on product, dose and coverage; branded-injection starting offers have dose and eligibility conditions. Confirm the entire advance charge, next renewal and pharmacy supply.
Read the full Ro review to compare the care pathway, prescription and recurring order.
7. Mochi Health: an ongoing access charge
Mochi combines provider access and nutrition-oriented support with a separate medication charge. Its current catalogue distinguishes branded medicines and compounded options. The exact selected medicine and diagnostics are outside the membership, so a product-card floor should not be mistaken for the complete monthly plan. Mochi’s monthly membership can be compared with its new-member introduction, while medicine and diagnostics remain extra. Ask how the medication supply is billed so the complete plan is not mistaken for one flexible access payment.
Read the dated Mochi membership update for the introductory offer and its limits. Its compounded medication cards say semaglutide as low as $60 and tirzepatide as low as $90, but quantity, selected strength and fulfillment terms need confirmation; those are additional floors, not complete membership-inclusive orders.
Compare cash committed at the first order and the next scheduled charge, not only a yearly equivalent. A smaller order may fit a cautious start, provided it follows the clinician’s plan. Make sure the selected supply and support are workable before accepting automatic renewal.
Payment flexibility is different from prescription suitability. A clinician may recommend additional assessment or another treatment. Do not arrange overlapping supplies from separate services to solve a billing concern without discussing the existing prescription and planned transition.
Original references are retained below. Later observations and their source dates are identified in the dated updates and research notes. Advertising describes an offer; it is not independent verification of treatment outcomes.